once it breaks out above those key overhead resistance levels at $2.05 to $2.10 a share with high volume. Look for volume on that move that hits near or above its three-month average action of 1.07 million shares. If that breakout gets underway soon, then shares of ABIO could easily soar higher towards my first target zones of $2.50 to $3 a share. If those levels get taken out with volume, then ABIO has an excellent chance of tagging $4 a share in the next few months, especially if we get some positive news on Gencaro. http://www.thestreet.com/story/12527111/1/small-cap-biotech-on-the-verge-of-a-breakout-abio.html?puc=yahoo&cm_ven=YAHOO
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.